Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Manual versus commercial cardioplegia solution in elective CABG surgery
IRCT20200825048515N80Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Feb 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of potassium chloride, magnesium sulfate, lidocaine and sodium bicarbonate in coronary arteriosclerosis (2 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoints: Potassium level, Magnesium level and 4 more. Started Feb 2025; status: completed.
02
Drugs
potassium chloridemagnesium sulfatelidocainesodium bicarbonate
03
Conditions
coronary arteriosclerosis
Beyond the preview
Go deeper on IRCT20200825048515N80.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200825048515N80.